RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$3.7K total
EMC Capital Management
$3.0K--
TD Waterhouse Canada Inc.
$4120.0%
Purpose Unlimited Inc.
$2590.0%
Mosley Wealth Management
$1New
Miller Global Investments, LLC
$1New
See all 5 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/RVPH

Loading ratio trend…

RVPH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH): stock profile, AI score and financials

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. RVPH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of RVPH by reported 13-F value include EMC Capital Management, TD Waterhouse Canada, Purpose Unlimited, based on the most recent SEC filings. RVPH trades on the Nasdaq exchange and files with the SEC under CIK 1742927. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RVPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for REVIVA PHARMACEUTICALS HOLDINGS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1742927 →